Medicenna Therapeutics Corp.

C$0.44As of Sun 8 Nov 2026, 12:00 UTC
TSX:MDNAHealthcare
Country Canada
PE (Fwd) •••
TSR 10Y CAGR (18.11%)
Div yield —
ROE (227.57%)
Biotechnology
Beta (5Y) 2.21
PE TTM —
TSR TTM (70.27%)
Mkt cap C$40.61M
ROIC (168.57%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$0.57
29.58%
(75.25%)
Sell 0|4|6|12|11
3Q26
4Q26
1Q27
2Q27
Earnings per share$
0.01
0.01
0.01
0.01
14.79%
25.46%
19.85%
12.21%
Revenue$M
2.286
2.402
2.509
2.507
14.99%
17.22%
18.36%
13.61%
Peers (US$28.75M)
Cap (US$)
PE
28.69M
—
Capital
TTM
5Y
10Y
Leveragex
0.165
(0.029)
(0.034)
EBIT/Intx
0.277
0.175
0.200
Own earn%
(0.53)
(4.95)
(4.77)
Sh yield%
16.68
36.87
42.53
Owners
Insiders/Inst%
6.82
28.45
Short interest%
1.22
SBC / revenue%
1.25
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
19
Op margin range%
10–17
$1 testx
—
Incr. ROIC%
2